DEDAL 2020

Multi-center, prospective clinical trial evaluating the possibility of patients making independent and safe DECisions regarding the use of Tadalafil Polpharma 10 mg film-coated tablets (TaDALafil) for erectile dysfunction

Ladies and Gentlemen,
Mrs. Doctor, Mr. Doctor

We invite you to participate in a multi-center clinical trial aimed at assessing patients' awareness of their health status in order to safely and independently use a medicinal product containing tadalafil without medical supervision.

The diagnostic and therapeutic process is a set of interrelated actions. Each of them is the result of certain decisions and carries certain clinical consequences. That is why it is so important to verify the patient's knowledge and ability to make the right decision that will not lead to medical dilemmas.

The results obtained in the study will be a step towards changing the availability category of the medicinal product, thus increasing the chances of patients with erectile dysfunction to have more access to treatment. From the perspective of the study goal, your active participation is crucial for the success of the entire project.

eCRF i Data Management
tel: +48 666 069 834
email: [email protected]
tel: +48 506 877 736
email: [email protected]